Risk of 30-Day All-Cause Readmission in Patients With ILD After COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Annals of the American Thoracic Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data
Ann Am Thorac Soc 2024 Mar 01;21(3)428-437, A Vaeli Zadeh, R Dinparastisaleh, A Vaezi, D Bandyopadhyay, I Rubinstein, HZ Baig, R Calderon-Candelario, A Hashemi Shahraki, T Kawasaki, JM Magnusson, LO Larsson, A Sharafkhaneh, JD Herazo-Maya, AS Lee, M MirsaeidiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.